Though SE was the most effective therapy for Bowen disease, the risk for recurrence with 5-FU and MAL-PDT was negligible.
Yousef and Finger review results of clinical treatment of 101 squamous conjunctival and corneal tumors in 99 patients with at least 6 months (mean, 22 months) of follow-up. The median age of the group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results